SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001609351-16-000107
Filing Date
2016-11-04
Accepted
2016-11-04 16:30:09
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spark-201693010xq.htm 10-Q 934592
2 EXHIBIT 31.1 spark-2016930exx311.htm EX-31.1 21900
3 EXHIBIT 31.2 spark-2016930exx312.htm EX-31.2 21899
4 EXHIBIT 32.1 spark-2016930exx321.htm EX-32.1 6995
5 EXHIBIT 32.2 spark2016930ex-322.htm EX-32.2 6874
  Complete submission text file 0001609351-16-000107.txt   3852955

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT once-20160930.xml EX-101.INS 462450
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT once-20160930.xsd EX-101.SCH 32296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT once-20160930_cal.xml EX-101.CAL 59332
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT once-20160930_def.xml EX-101.DEF 170523
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT once-20160930_lab.xml EX-101.LAB 471848
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT once-20160930_pre.xml EX-101.PRE 289008
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36819 | Film No.: 161975530
SIC: 2836 Biological Products, (No Diagnostic Substances)